Article
The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy
1 Jan 2015
Abstract excerpt
Ischemic cardiomyopathy (ICM) is becoming a leading cause of morbidity and mortality in the whole world. Stem cell-based therapy is emerging as a promising option for treatment of ICM. Several stem cell types including cardiac-derived stem cells (CSCs), bone marrow-derived stem cells, mesenchymal stem cells (MSCs), skeletal myoblasts (SMs), and CD34(+) and CD 133(+) stem cells have been applied in clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
